Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Mahévas M[au]:

Pathogenesis of immune thrombocytopenia. Audia S et al. Autoimmun Rev. (2017)

How we manage immune thrombocytopenia in the elderly. Mahévas M et al. Br J Haematol. (2016)

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists. Guitton Z et al. Rheumatology (Oxford). (2018)

Search results

Items: 1 to 50 of 64

1.

Anti-CD20-mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives.

Crickx E, Weill JC, Reynaud CA, Mahévas M.

Kidney Int. 2020 Jan 30. pii: S0085-2538(20)30108-3. doi: 10.1016/j.kint.2019.12.025. [Epub ahead of print] Review.

PMID:
32229095
2.

Systemo-pulmonary shunting and acute chest syndrome in a patient with SC sickle-cell disease.

Schlemmer F, Gellen-Dautremer J, Carette MF, de Prost N, Spagnolo S, Deux JF, Fartoukh M, Naccache JM, Habibi A, Mahevas M, Bartolucci P, Mekontso Dessap A, Maitre B.

Respir Med Res. 2019 Nov 21;77:21-23. doi: 10.1016/j.resmer.2019.11.001. [Epub ahead of print] No abstract available.

PMID:
32036282
3.

Acute Hippocampal Encephalopathy in Heavy Cannabis Users: About 2 Cases.

Nguyen QTR, Gravier A, Lesoil C, Bedet A, Petit-Hoang C, Mahevas M, Mekontso-Dessap A, Hodel J, Bachoud-Lévi AC, Cleret de Langavant L.

Am J Med. 2019 Dec 24. pii: S0002-9343(19)31096-4. doi: 10.1016/j.amjmed.2019.11.018. [Epub ahead of print]

PMID:
31877268
4.

Atypical systemic sarcoid-like granulomatosis in two patients treated with BRAF and MEK inhibitors.

Assan F, Schlemmer F, Assie JB, Mahevas M, Sustronck P, Ortonne N, Velter C, Fardet L, Zehou O.

Eur J Dermatol. 2019 Oct 1;29(5):556-557. doi: 10.1684/ejd.2019.3640. No abstract available.

PMID:
31649010
5.

Methylprednisolone-induced immune thrombocytopenia.

Dubert M, Le Toriellec E, Croisille L, Thomas L, Ducreux M, Froissart A, Herbrecht R, Lebrun-Vignes B, Marolleau JP, Méric JB, Mahevas M, Michel M, Bierling P.

Am J Hematol. 2020 Jan;95(1):E13-E16. doi: 10.1002/ajh.25645. Epub 2019 Oct 31. No abstract available.

PMID:
31598982
6.

Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.

Deshayes S, Khellaf M, Zarour A, Layese R, Fain O, Terriou L, Viallard JF, Cheze S, Graveleau J, Slama B, Audia S, Cliquennois M, Ebbo M, Le Guenno G, Salles G, Bonmati C, Teillet F, Galicier L, Lambotte O, Hot A, Lefrère F, Mahévas M, Canoui-Poitrine F, Michel M, Godeau B.

Am J Hematol. 2019 Dec;94(12):1314-1324. doi: 10.1002/ajh.25632. Epub 2019 Oct 8.

PMID:
31489694
7.

Bortezomib and dexamethasone, an original approach for treating multi-refractory warm autoimmune haemolytic anaemia.

Fadlallah J, Michel M, Crickx E, Limal N, Costedoat N, Malphettes M, Fieschi C, Galicier L, Oksenhendler E, Godeau B, Audia S, Mahévas M.

Br J Haematol. 2019 Oct;187(1):124-128. doi: 10.1111/bjh.16009. Epub 2019 Jun 2.

PMID:
31155716
8.

[Hemophagocytic lymphohistiocytosis with granulomatosis and diffuse T-cell infiltration associated with disseminated Nocardiosis and pulmonary infection due to Streptomyces spp].

Canouï E, Ingen-Housz-Oro S, Ortonne N, Lebeaux D, Rodriguez-Nava V, Godeau B, Mahévas M.

Rev Med Interne. 2019 Jul;40(7):457-461. doi: 10.1016/j.revmed.2019.04.013. Epub 2019 May 15. French.

PMID:
31103241
9.

Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma.

Crickx E, Poullot E, Moulis G, Goulabchand R, Fieschi C, Galicier L, Meignin V, Coppo P, Delarue R, Casasnovas O, Roos-Weil D, de Leval L, Parrens M, Michel M, Dupuis J, Le Bras F, Fataccioli V, Martin-Garcia N, Godeau B, Haïoun C, Gaulard P, Mahévas M.

Eur J Haematol. 2019 Jul;103(1):35-42. doi: 10.1111/ejh.13239. Epub 2019 May 30.

PMID:
30985955
10.

Autologous111 Indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonists.

Mahevas M, Van Eeckhoudt S, Moulis G, Limal N, Languille L, Bierling P, Dossier A, Duriez F, Galicier L, Morin AS, Tamburini J, Chaoui D, Bouscary D, Jijakli AAL, Khellaf M, Vaida I, Michel M, Vercellino L, Jaddi H, Yollant A, Dosquet C, Godeau B, Chomienne C.

Br J Haematol. 2019 Aug;186(3):e44-e47. doi: 10.1111/bjh.15890. Epub 2019 Apr 4. No abstract available.

PMID:
30950041
11.

Monoclonal Gammopathy, Arthralgias, and Recurrent Fever Syndrome: A New Autoinflammatory Syndrome?

Terré A, Talbot A, Louvrier C, Picque JB, Mahévas M, Boutboul D, Amselem S, Giurgea I, Grateau G, Georgin-Lavialle S; French Network of Dysimmune Disorders Associated with Hemopathies.

J Rheumatol. 2019 Nov;46(11):1535-1539. doi: 10.3899/jrheum.181204. Epub 2019 Mar 15.

PMID:
30877203
12.

Severe, non specific symptoms in non-typhoidal Salmonella infections in adult patients with sickle cell disease: a retrospective multicentre study.

Guery R, Habibi A, Arlet JB, Lionnet F, de Lastours V, Decousser JW, Mainardi JL, Razazi K, Baranes L, Bartolucci P, Godeau B, Galacteros F, Michel M, Mahevas M.

Infect Dis (Lond). 2018 Nov - Dec;50(11-12):822-830. doi: 10.1080/23744235.2018.1500706. Epub 2018 Oct 14.

PMID:
30317897
13.

Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.

Piel-Julian ML, Mahévas M, Germain J, Languille L, Comont T, Lapeyre-Mestre M, Payrastre B, Beyne-Rauzy O, Michel M, Godeau B, Adoue D, Moulis G; CARMEN investigators group.

J Thromb Haemost. 2018 Sep;16(9):1830-1842. doi: 10.1111/jth.14227. Epub 2018 Aug 12.

PMID:
29978544
14.

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.

Guitton Z, Terriou L, Lega JC, Nove-Josserand R, Hie M, Amoura Z, Bussel JB, Hamidou M, Rosenthal E, Lioger B, Chauveau D, Chaminade A, Magy-Bertrand N, Michel M, Audia S, Godeau B, Mahevas M.

Rheumatology (Oxford). 2018 Aug 1;57(8):1432-1438. doi: 10.1093/rheumatology/key119.

PMID:
29757439
15.

Systematic detection of portal or splenic vein thrombosis after splenectomy for immune cytopenia.

Morbieu C, Brunetti F, Baranès L, Languille L, Limal N, Loustau V, Bierling P, Michel M, Godeau B, Mahévas M.

Am J Hematol. 2018 Jul;93(7):E170-E172. doi: 10.1002/ajh.25120. No abstract available.

16.

BAFF and CD4+ T cells are major survival factors for long-lived splenic plasma cells in a B-cell-depletion context.

Thai LH, Le Gallou S, Robbins A, Crickx E, Fadeev T, Zhou Z, Cagnard N, Mégret J, Bole C, Weill JC, Reynaud CA, Mahévas M.

Blood. 2018 Apr 5;131(14):1545-1555. doi: 10.1182/blood-2017-06-789578. Epub 2018 Jan 29.

PMID:
29378696
17.

Clinical severity in adult warm autoimmune hemolytic anemia and its relationship to antibody specificity.

Chadebech P, Loustau V, Janvier D, Languille L, Ripa J, Tamagne M, Bierling P, Djoudi R, Godeau B, Michel M, Pirenne F, Mahévas M.

Haematologica. 2018 Jan;103(1):e35-e38. doi: 10.3324/haematol.2017.175976. Epub 2017 Oct 12. No abstract available.

18.

Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.

Heidelberger V, Ingen-Housz-Oro S, Marquet A, Mahevas M, Bessis D, Bouillet L, Caux F, Chapelon-Abric C, Debarbieux S, Delaporte E, Duval-Modeste AB, Fain O, Joly P, Marchand-Adam S, Monfort JB, Noël N, Passeron T, Ruivard M, Sarrot-Reynauld F, Verrot D, Bouvry D, Fardet L, Chosidow O, Sève P, Valeyre D.

JAMA Dermatol. 2017 Jul 1;153(7):681-685. doi: 10.1001/jamadermatol.2017.1162. Erratum in: JAMA Dermatol. 2017 Aug 1;153(8):837.

19.

Pathogenesis of immune thrombocytopenia.

Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B.

Autoimmun Rev. 2017 Jun;16(6):620-632. doi: 10.1016/j.autrev.2017.04.012. Epub 2017 Apr 17. Review.

PMID:
28428120
20.

Autoimmune cytopenias associated with inflammatory bowel diseases: Insights from a multicenter retrospective cohort.

Uzzan M, Galicier L, Gornet JM, Oksenhendler E, Fieschi C, Allez M, Bouhnik Y, Kirchgesner J, Boutboul D, Treton X, Gérard L, Mahévas M, Cosnes J, Amiot A.

Dig Liver Dis. 2017 Apr;49(4):397-404. doi: 10.1016/j.dld.2016.12.006. Epub 2016 Dec 23.

PMID:
28063954
21.

Severe Thrombocytopenia after Zika Virus Infection, Guadeloupe, 2016.

Boyer Chammard T, Schepers K, Breurec S, Messiaen T, Destrem AL, Mahevas M, Soulillou A, Janaud L, Curlier E, Herrmann-Storck C, Hoen B.

Emerg Infect Dis. 2017 Apr;23(4):696-698. doi: 10.3201/eid2304.161967. Epub 2017 Apr 15.

22.

Long-term complications of splenectomy in adult immune thrombocytopenia.

Thai LH, Mahévas M, Roudot-Thoraval F, Limal N, Languille L, Dumas G, Khellaf M, Bierling P, Michel M, Godeau B.

Medicine (Baltimore). 2016 Nov;95(48):e5098.

23.

Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.

Bitoun S, Bouvry D, Borie R, Mahevas M, Sacre K, Haroche J, Psimaras D, Pottier C, Mathian A, Hie M, Boutin DL, Papo T, Godeau B, Valeyre D, Nunes H, Amoura Z, Cohen Aubart F.

Neurology. 2016 Dec 13;87(24):2517-2521. Epub 2016 Nov 16.

PMID:
27856779
24.

[Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].

Weber E, Moulis G, Mahévas M, Guy C, Lioger B, Durieu I, Hunault M, Ramanantsoa M, Royer B, Default A, Pérault-Pochat MC, Moachon L, Bernard N, Bardy G, Jonville-Bera AP, Geniaux H, Godeau B, Cathébras P.

Rev Med Interne. 2017 Mar;38(3):167-175. doi: 10.1016/j.revmed.2016.09.016. Epub 2016 Oct 25. French.

PMID:
27793553
25.

Seasonal variations of incident primary immune thrombocytopenia in adults: An ecological study.

Moulis G, Guénin S, Limal N, Michel M, Bierling P, Godeau B, Mahévas M.

Eur J Intern Med. 2017 Jan;37:e26-e28. doi: 10.1016/j.ejim.2016.09.025. Epub 2016 Oct 7. No abstract available.

PMID:
27727074
26.

Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.

Mahévas M, Gerfaud-Valentin M, Moulis G, Terriou L, Audia S, Guenin S, Le Guenno G, Salles G, Lambotte O, Limal N, Viallard JF, Cheze S, Tomowiak C, Royer B, Neel A, Debouverie O, Hot A, Durieu I, Perlat A, Cliquennois M, Deteix C, Michel M, Godeau B.

Blood. 2016 Sep 22;128(12):1625-30. doi: 10.1182/blood-2016-03-704734. Epub 2016 Jun 27.

PMID:
27354722
27.

How we manage immune thrombocytopenia in the elderly.

Mahévas M, Michel M, Godeau B.

Br J Haematol. 2016 Jun;173(6):844-56. doi: 10.1111/bjh.14067. Epub 2016 Apr 7. Review.

PMID:
27062054
28.

TNFA, ANXA11 and BTNL2 Polymorphisms in CVID Patients with Granulomatous Disease.

Boutboul D, Vince N, Mahevas M, Bories JC, Fieschi C; DefI Study Group.

J Clin Immunol. 2016 Feb;36(2):110-2. doi: 10.1007/s10875-016-0234-0. Epub 2016 Jan 18. No abstract available.

PMID:
26783045
29.

Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis.

Moulis G, Audemard-Verger A, Arnaud L, Luxembourger C, Montastruc F, Gaman AM, Svenungsson E, Ruggeri M, Mahévas M, Gerfaud-Valentin M, Brainsky A, Michel M, Godeau B, Lapeyre-Mestre M, Sailler L.

Autoimmun Rev. 2016 Mar;15(3):203-9. doi: 10.1016/j.autrev.2015.11.001. Epub 2015 Dec 19. Review.

PMID:
26708169
30.

NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia.

Ebbo M, Audonnet S, Grados A, Benarous L, Mahevas M, Godeau B, Viallard JF, Piperoglou C, Cognet C, Farnarier C, Harlé JR, Schleinitz N, Vély F.

Clin Immunol. 2017 Apr;177:18-28. doi: 10.1016/j.clim.2015.11.005. Epub 2015 Nov 18.

PMID:
26598010
31.

Cutaneous rash and dapsone-induced hypersensitivity syndrome a common manifestation in adult immune thrombocytopenia. Presentation and outcome in 16 cases.

Sauvetre G, MahÉvas M, Limal N, Guillaud C, Khellaf M, Bierling P, Languille L, Delbos F, Noizat-Pirenne F, Michel M, Godeau B.

Am J Hematol. 2015 Oct;90(10):E201-2. doi: 10.1002/ajh.24068. Epub 2015 Sep 1. No abstract available.

32.

Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab.

Mahévas M, Michel M, Vingert B, Moroch J, Boutboul D, Audia S, Cagnard N, Ripa J, Menard C, Tarte K, Mégret J, Le Gallou S, Patin P, Thai L, Galicier L, Bonnotte B, Godeau B, Noizat-Pirenne F, Weill JC, Reynaud CA.

J Autoimmun. 2015 Aug;62:22-30. doi: 10.1016/j.jaut.2015.05.006. Epub 2015 Jun 23.

PMID:
26112660
33.

Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France.

Moulis G, Lapeyre-Mestre M, Mahévas M, Montastruc JL, Sailler L.

Am J Hematol. 2015 Apr;90(4):301-5. doi: 10.1002/ajh.23930. Epub 2015 Mar 2.

34.

The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease.

Noizat-Pirenne F, Habibi A, Mekontso-Dessap A, Razazi K, Chadebech P, Mahevas M, Vingert B, Bierling P, Galactéros F, Bartolucci P, Michel M.

Vox Sang. 2015 Apr;108(3):262-7. doi: 10.1111/vox.12217. Epub 2014 Dec 18.

PMID:
25523469
35.

[Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative patient].

Salle V, Desblache J, Mahevas M, Smail A, Schmidt J, Capiod JC, Ducroix JP.

Med Mal Infect. 2014 Sep;44(9):437-40. doi: 10.1016/j.medmal.2014.07.002. Epub 2014 Sep 16. French. No abstract available.

PMID:
25239145
36.

[Abdominal pain and chronic diarrhea in a 55-year-old woman].

Schiller D, Schöfl R, Mahévas M.

Rev Med Interne. 2015 Feb;36(2):135-9. doi: 10.1016/j.revmed.2014.08.001. Epub 2014 Sep 12. French. No abstract available.

PMID:
25225068
37.

Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.

Levy R, Mahévas M, Galicier L, Boutboul D, Moroch J, Loustau V, Guillaud C, Languille L, Fain O, Bierling P, Khellaf M, Michel M, Oksenhendler E, Godeau B.

Autoimmun Rev. 2014 Oct;13(10):1055-63. doi: 10.1016/j.autrev.2014.08.036. Epub 2014 Aug 27. Review.

PMID:
25183241
38.

Brief Report: Involvement of TNFRSF11A molecular defects in autoinflammatory disorders.

Jéru I, Cochet E, Duquesnoy P, Hentgen V, Copin B, Mitjavila-Garcia MT, Sheykholeslami S, Le Borgne G, Dastot-Le Moal F, Malan V, Karabina S, Mahevas M, Chantot-Bastaraud S, Lecron JC, Faivre L, Amselem S.

Arthritis Rheumatol. 2014 Sep;66(9):2621-7. doi: 10.1002/art.38727.

39.

Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients.

Roumier M, Loustau V, Guillaud C, Languille L, Mahevas M, Khellaf M, Limal N, Noizat-Pirenne F, Godeau B, Michel M.

Am J Hematol. 2014 Sep;89(9):E150-5. doi: 10.1002/ajh.23767. Epub 2014 Jun 19.

40.

Sickle-cell disease stroke throughout life: a retrospective study in an adult referral center.

Gueguen A, Mahevas M, Nzouakou R, Hosseini H, Habibi A, Bachir D, Brugière P, Lionnet F, Ribei JA, Godeau B, Girot R, Ibrahima V, Calvet D, Galactéros F, Bartolucci P.

Am J Hematol. 2014 Mar;89(3):267-72.

41.

The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study.

Mahévas M, Fain O, Ebbo M, Roudot-Thoraval F, Limal N, Khellaf M, Schleinitz N, Bierling P, Languille L, Godeau B, Michel M.

Br J Haematol. 2014 Jun;165(6):865-9. doi: 10.1111/bjh.12888. Epub 2014 Apr 12.

PMID:
24725224
42.

Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.

Mahévas M, Michel M, Weill JC, Reynaud CA.

Front Immunol. 2013 Dec 27;4:494. doi: 10.3389/fimmu.2013.00494. Review.

43.

[Post-splenectomy complications in primary immune thrombocytopenia. Literature review and preventive measures].

Mahévas M, Coignard-Biehler H, Michel M, Lortholary O, Godeau B.

Rev Med Interne. 2014 Jun;35(6):382-7. doi: 10.1016/j.revmed.2013.11.002. Epub 2013 Nov 26. Review. French.

PMID:
24290028
44.

Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.

Khellaf M, Chabrol A, Mahevas M, Roudot-Thoraval F, Limal N, Languille L, Bierling P, Michel M, Godeau B.

Am J Hematol. 2014 Feb;89(2):194-8. doi: 10.1002/ajh.23609. Epub 2013 Nov 20.

45.

Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia.

Audia S, Samson M, Mahévas M, Ferrand C, Trad M, Ciudad M, Gautheron A, Seaphanh F, Leguy V, Berthier S, Salles B, Martin L, Lorcerie B, Ortega-Deballon P, Facy O, Caillot D, Soudry-Faure A, Michel M, Godeau B, Larmonier N, Saas P, Janikashvili N, Bonnotte B.

Blood. 2013 Oct 3;122(14):2477-86. doi: 10.1182/blood-2013-03-491415. Epub 2013 Aug 20.

PMID:
23963041
46.

Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia.

Mahévas M, Ebbo M, Audia S, Bonnotte B, Schleinitz N, Durand JM, Chiche L, Khellaf M, Bierling P, Roudot-Thoraval F, Godeau B, Michel M.

Am J Hematol. 2013 Oct;88(10):858-61. doi: 10.1002/ajh.23518. Epub 2013 Sep 3.

47.

Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study.

Stehlé T, Joly D, Vanhille P, Boffa JJ, Rémy P, Mesnard L, Hoffmann M, Grimbert P, Choukroun G, Vrtovsnik F, Verine J, Desvaux D, Walker F, Lang P, Mahevas M, Sahali D, Audard V.

Orphanet J Rare Dis. 2013 Apr 30;8:65. doi: 10.1186/1750-1172-8-65.

48.

B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.

Mahévas M, Patin P, Huetz F, Descatoire M, Cagnard N, Bole-Feysot C, Le Gallou S, Khellaf M, Fain O, Boutboul D, Galicier L, Ebbo M, Lambotte O, Hamidou M, Bierling P, Godeau B, Michel M, Weill JC, Reynaud CA.

J Clin Invest. 2013 Jan;123(1):432-42. doi: 10.1172/JCI65689. Epub 2012 Dec 17.

49.

A case-control study to assess the risk of immune thrombocytopenia associated with vaccines.

Grimaldi-Bensouda L, Michel M, Aubrun E, Leighton P, Viallard JF, Adoue D, Magy-Bertrand N, Tisserand G, Khellaf M, Durand JM, Quittet P, Fain O, Bonnotte B, Morin AS, Limal N, Costedoat-Chalumeau N, Morel N, Pan-Petesch B, Decaux O, Mahevas M, Ruel M, Sacre K, Lefrere F, Abenhaim L, Godeau B; PGRx Immune Thrombocytopenia Study Group.

Blood. 2012 Dec 13;120(25):4938-44. doi: 10.1182/blood-2012-05-431098. Epub 2012 Oct 24.

PMID:
23100310
50.

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.

Patel VL, Mahévas M, Lee SY, Stasi R, Cunningham-Rundles S, Godeau B, Kanter J, Neufeld E, Taube T, Ramenghi U, Shenoy S, Ward MJ, Mihatov N, Patel VL, Bierling P, Lesser M, Cooper N, Bussel JB.

Blood. 2012 Jun 21;119(25):5989-95. doi: 10.1182/blood-2011-11-393975. Epub 2012 May 7.

Supplemental Content

Loading ...
Support Center